Close

Axsome Therapeutics (AXSM) Receives U.S. Patent Covering AXS-02 as Bone Marrow Treatment

January 27, 2016 6:36 AM EST Send to a Friend
Axsome Therapeutics, Inc. (Nasdaq: AXSM) announced that the U.S. Patent and Trademark Office has issued a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login